This study highlights the critical role of SLC16A4 in regulating lactate metabolism during COVID‐19 infection and suggests that SLC16A4 may be a potential therapeutic target for preventing or treating lung fibrosis. Here, SLC16A4 is linked to pulmonary fibrosis.